He is co-founder, shareholder and employee of Axovia Therapeutics Ltd. Right now, approximately 20 billion red blood cells ...
and red blood cells. We have expanded the potential of scICP-MS technology to mammalian cultured cells, developing a robust analytical technique for measuring elemental content in mammalian ...